enzh-TWfrdeitjaptrues

We would like to turn our spotlight to a wonderful couple, Ed & Marian Saltzman, who, through their generous donations, have provided invaluable help to the Bing Center.  Ed Saltzman, born in 1937, attended Hofstra University where he received his BS in Bio Chemistry. He served in the US Army Medical Corps, and then 11 years at Roche Laboratories as Director of Hospital Sales. He then founded Health Learning Systems Inc., United Weight Control, and Women's Health Alliance (sold to ABC TV).  He has served as vice president of the National Kidney Foundation, NYC, and the International Board at Haifa University, Israel.  He and Marian (Abraham) met while attending Hofstra. They were married in 1958 and have been blessed with 3 children and 8 grandchildren.

In January, 2000, Ed was diagnosed with Waldenstrom's Macroglobulinemia at the Cornell Medical Center. At that time, WM was considered an "orphan disease", with little research money available to study this disease.  Few treatment options were available, and there were few doctors with expertise in WM. In April, 2001, Ed was introduced to Dr. Steven Treon, who was heading up a fairly new research group at the Dana-Farber, "The Waldenstrom's Macroglobulinemia (WM) Program". Unlike other WM research efforts, which were typically combined with Multiple Myeloma research, the "WM Program" was 100% dedicated to the research and clinical treatment of WM.  For the next ten years, Ed continued his treatments at the Dana-Farber WM Program (renamed "The Bing Center for WM" in 2005). He is currently working with his local NYC medical team, but keeps in regular touch with the Bing Center.

In 2002, Ed & Marian held a fundraiser at their Hamptons home to raise money for the WM Program. At the end of the event, disappointed with the financial result, Ed took out his checkbook and wrote a personal check to the WM Program.  His contribution was instrumental in funding the initial development of the program's website. The website quickly became an invaluable resource for WM patients and clinicians alike. In 2009, the website was redesigned to its current format.  It has since become a "one-stop-shop" source for the latest published research, clinical trials, and other information for WM. Ed & Marian's generosity has also provided the impetus for other WM-related websites, specifically devoted to our bi-annual WM Workshops, Clinical Trials Group, and Patient/Physician Summit meetings. These websites have helped make WM patients some of the most educated in the world about their disease.  Ed and Marian have been instrumental in funding these efforts, and we would like to say, "Thank you!"

If you wish to contribute to the Bing Center, you may visit the following link.  100% of your contribution goes to the funding of research into Waldenstrom’s Macroglobulinemia, and may be tax-deductable.

http://www.myjimmyfundpage.org/give/steventreon

Latest Bing Center News

Video from CBS-4 Boston - Dr. Treon discusses COVID-19 / Ibrutinib Trial

Video from CBS-4 Boston - Dr. Treon discusses COVID-19 / Ibrutinib Trial

Researchers say ibrutinib seems to protect those with COVID-19 from lung damage and respiratory distress. They will now conduct a trial to see if the medication can reduce a patient’s need for a ventilator, improve survival and reduce their time in the hospital.

Read more..

COVID-19 Information for Our Patients

COVID-19 Information for Our Patients

The Bing Center would like to share this important information with all of our patients and interested parties to help us all manage through this unprecedented crisis in the best and most productive way possible.

Read more..

Waldenström Macroglobulinemia Specialty Channel

Waldenström Macroglobulinemia Specialty Channel

Welcome to the Oncology Learning Network Waldenstrom Macroglobulinemia Specialty Channel. Here you will find articles dedicated to the research and treatment of WM.

Read more..

Dana-Farber to Test Blood Cancer Drug in COVID-19

Dana-Farber to Test Blood Cancer Drug in COVID-19

Scientists at Dana-Farber have launched a clinical test of a blood-cancer drug in patients that have the COVID-19 virus. The test follows several case reports in which the drug, ibrutinib, appeared to protect against lung damage and respiratory distress caused by the novel virus.

Read more..

BeiGene Announces Clinical and Non-Clinical Data on BRUKINSA™ (Zanubrutinib) and Tislelizumab to Be Presented at the 25th European Hematology Association (EHA) Virtual Congress

BeiGene Announces Clinical and Non-Clinical Data on BRUKINSA™ (Zanubrutinib) and Tislelizumab to Be Presented at the 25th European Hematology Association (EHA) Virtual Congress

CAMBRIDGE, Mass. and BEIJING, China, May 14, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that clinical and non-clinical data on BTK inhibitor BRUKINSA™

Read more..

Understanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Therapies

Understanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Therapies

We are excited to announce this new webcast on diagnosis, risk stratification, and current and emerging therapies for Waldenström's Macroglobulinemia (WM).

Read more..

Watch Dr. Jorge Castillo’s engaging “Ask the Doctor” session

Watch Dr. Jorge Castillo’s engaging “Ask the Doctor” session

Fifty WMers from the Philly WM Support Group enjoyed a lively, engaging and informative conversation with Dr. Jorge Castillo, Clinical Director of the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute.

Read more..

Drs. Castillo and Kastritis have joined the IWMF Scientific Advisory Committee

Drs. Castillo and Kastritis have joined the IWMF Scientific Advisory Committee

The IWMF is proud to welcome two new members to its Scientific Advisory Committee (SAC) chaired by Dr. Steven Ansell of the Mayo Clinic and Dr. Stephen Treon of the Dana-Farber Cancer Institute. The new members, Dr. Jorge Castillo from Dana-Farber, Boston, USA, and Dr. Efstathios Kastritis of Athens, Greece, were invited to participate because of their expertise in specific research areas identified by the IWMF-LLS Strategic Research Roadmap for WM.

Read more..

Waldenstrom's Song - Tim Salz, UC Berkeley, CA

Waldenstrom's Song - Tim Salz, UC Berkeley, CA

This is a song I wrote for all of my fellow Wallies out there. Thanks for watching.

Read more..

Robert J. Manning, FM, RNG

Robert J. Manning, FM, RNG

I first met Bob Manning in early 2004 when I started volunteering at the Bing Center. My boss introduced me to Bob, and said 3 words, "Help this guy". The first thing I noticed was Bob's badge, which contained his name, followed by the credentials, FM, RNG. Bob told me they meant, "Former Marine, Real Nice Guy". That's when I knew this wasn't going to be a boring relationship.

Read more..